{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"}],"units":"Participants"}],"description":"Time from documentation of tumor response to disease progression.","groups":[{"description":"MLN9708 4mg by mouth weekly (days 1, 8, 15) every 28 days.","id":"OG000","title":"MLN9708"}],"paramType":"NUMBER","populationDescription":"Although 12 patients were analyzable, only one patient responded to treatment and therefore only 1 patient is represented for the duration of response.","reportingStatus":"POSTED","timeFrame":"24 months after initiation of study treatment","title":"Duration of Response","type":"SECONDARY","unitOfMeasure":"months"}